Dr. Kathleen Moore, M.D., MS
Claim this profileUniversity of Oklahoma Health Sciences Center
About Kathleen Moore, M.D., MS
Education:
- Earned an MD from the University of Oklahoma College of Medicine in 1995.
- Obtained an MS in Clinical Research from the University of Oklahoma Health Sciences Center in 2007.
Experience:
- Director of the Gynecologic Oncology Fellowship Program at Stephenson Cancer Center, University of Oklahoma Health Sciences Center.
- Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma Health Sciences Center.
- Renowned gynecologic oncologist and clinical researcher, specializing in ovarian cancer and other gynecologic malignancies.
Area of expertise
Ovarian Cancer
Kathleen Moore, M.D., MS has run 19 trials for Ovarian Cancer. Some of their research focus areas include:
Endometrial Cancer
Kathleen Moore, M.D., MS has run 10 trials for Endometrial Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Oklahoma Health Sciences Center
University Of Oklahoma
Clinical Trials Kathleen Moore, M.D., MS is currently running
SHetA2
for Gynecologic Cancers
The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
Recruiting
1 award
Phase 1
Behavioral Weight Loss + Progestin
for Endometrial Hyperplasia
Up to 60% of endometrial cancer cases are attributed to obesity, in part because obesity promotes development of atypical endometrial hyperplasia (AEH), and up to 40% of women with AEH go on to develop endometrial cancer. The increasing prevalence of obesity in premenopausal women has resulted in increasing rates of AEH in this age group. Hysterectomy with removal of the fallopian tubes and ovaries is 100% effective in preventing endometrial cancer, but this approach results in infertility. Fertility-sparing treatments exist, such as treatment with oral or intrauterine progestin, but these treatments do not work uniformly and do not combat the underlying cause of endometrial cancer, which is obesity and metabolic syndrome. Additionally, up to 41% of women on progestin eventually experience relapse of AEH or endometrial cancer. Third, many patients have insulin resistance that may worsen with progestin therapy. Thus, to improve treatment of AEH and grade 1 endometrial cancer, prevent and reverse endometrial cancer, and allow women to preserve their fertility, the investigators must integrate an effective weight loss strategy to be given with progestin treatment. It is the hypothesis that premenopausal women with AEH desire uterine preservation will be more likely to have atypia-free uterine preservation at one year if they receive progestin in combination with a behavioral weight loss intervention versus progestin plus enhanced usual care.
Recruiting
1 award
Phase 2
More about Kathleen Moore, M.D., MS
Clinical Trial Related
1 year of experience running clinical trials · Led 32 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Kathleen Moore, M.D., MS has experience with
- Paclitaxel
- Olaparib
- Carboplatin
- Binimetinib
- Niraparib
- Defactinib
Breakdown of trials Kathleen Moore, M.D., MS has run
Ovarian Cancer
Endometrial Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathleen Moore, M.D., MS specialize in?
Kathleen Moore, M.D., MS focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kathleen Moore, M.D., MS currently recruiting for clinical trials?
Yes, Kathleen Moore, M.D., MS is currently recruiting for 10 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Kathleen Moore, M.D., MS has studied deeply?
Yes, Kathleen Moore, M.D., MS has studied treatments such as Paclitaxel, Olaparib, Carboplatin.
What is the best way to schedule an appointment with Kathleen Moore, M.D., MS?
Apply for one of the trials that Kathleen Moore, M.D., MS is conducting.
What is the office address of Kathleen Moore, M.D., MS?
The office of Kathleen Moore, M.D., MS is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.